Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. Journal of Reports in Pharmaceutical Sciences
  4. Articles

  5. Antitumoral Effects of Digoxin in The Liver Cancer Cell Line is mediated through Induction of Apoptosis and Down Regulation of HIF-Α Expression
  6. Scopus by Title (Ref)

Journal of Reports in Pharmaceutical Sciences

Home
Current IssueAll IssuesIn PressAccepted ManuscriptsSearch
Instructions
Journal InformationEditors & BoardsIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Publication Malpractice StatementReviewer and AE Registration FormSupportContact Us
APCAnnouncement of New Publisher
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. Evaluation of the Anti-Mycobacterial and Anti-Inflammatory Activities of the New Cardiotonic Steroid γ-Benzylidene Digoxin-15 in Macrophage Models of Infection

- Magalhães D.W.A. , et al.

2. DIGOXIN EXHIBITS ANTICANCER ACTIVITY IN A375 AND RPMI-7951 CUTANEOUS MELANOMA CELLS: A DRUG REPURPOSING APPROACH

- Dahma R. , et al.

3. Digoxin and its Na+/K+-ATPase-targeted actions on cardiovascular diseases and cancer

- Ren Y. , et al.

4. Implications for glycosylated compounds and their anti-cancer effects

- Pourakbari R. , et al.

5. Prospects and Therapeutic Applications of Cardiac Glycosides in Cancer Remediation

- Ayogu J.I. , et al.

HomeInstructionsAPCAnnouncement of New Publisher

Articles

  • Current Issue
  • All Issues
  • In Press
  • Accepted Manuscripts
  • Search

About Journal

  • Journal Information
  • Editors & Boards
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Publication Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.